JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Sees Large Increase in Short Interest

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 477,000 shares, a growth of 16.7% from the November 15th total of 408,600 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

JCR Pharmaceuticals Price Performance

Shares of JCR Pharmaceuticals stock remained flat at $4.57 during trading on Monday. JCR Pharmaceuticals has a 12 month low of $4.30 and a 12 month high of $4.70. The firm’s 50 day simple moving average is $4.57 and its 200 day simple moving average is $4.69.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.